Classical anticytokinins do not interact with cytokinin receptors but inhibit cyclin-dependent kinases.
Cytokinins are a class of plant hormones that regulate the cell cycle and diverse developmental and physiological processes. Several compounds have been identified that antagonize the effects of cytokinins. Based on structural similarities and competitive inhibition, it has been assumed that these anticytokinins act through a common cellular target, namely the cytokinin receptor. Here, we examined directly the possibility that various representative classical anticytokinins inhibit the Arabidopsis cytokinin receptors CRE1/AHK4 (cytokinin response 1/Arabidopsis histidine kinase 4) and AHK3 (Arabidopsis histidine kinase 3). We show that pyrrolo[2,3-d]pyrimidine and pyrazolo[4,3-d]pyrimidine anticytokinins do not act as competitors of cytokinins at the receptor level. Flow cytometry and microscopic analyses revealed that anticytokinins inhibit the cell cycle and cause disorganization of the microtubular cytoskeleton and apoptosis. This is consistent with the hypothesis that they inhibit regulatory cyclin-dependent kinase (CDK) enzymes. Biochemical studies demonstrated inhibition by selected anti-cytokinins of both Arabidopsis and human CDKs. X-ray determination of the crystal structure of a human CDK2-anticytokinin complex demonstrated that the antagonist occupies the ATP-binding site of CDK2. Finally, treatment of human cancer cell lines with anticytokinins demonstrated their ability to kill human cells with similar effectiveness as known CDK inhibitors.
Spíchal
Lukás
L
Laboratory of Growth Regulators, Institute of Experimental Botany, AS CR and Palacký University, Slechtitelů 11, Olomouc, Czech Republic.
Krystof
Vladimír
V
Paprskárová
Martina
M
Lenobel
René
R
Styskala
Jakub
J
Binarová
Pavla
P
Cenklová
Vera
V
De Veylder
Lieven
L
Inzé
Dirk
D
Kontopidis
George
G
Fischer
Peter M
PM
Schmülling
Thomas
T
Strnad
Miroslav
M
D017209:Apoptosis; D017360:Arabidopsis / Q000378:metabolism*; D029681:Arabidopsis Proteins / Q000378:metabolism*; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D002352:Carrier Proteins; D002453:Cell Cycle; D049109:Cell Proliferation / Q000187:drug effects; D018360:Crystallography, X-Ray; D051357:Cyclin-Dependent Kinase 2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003583:Cytokinins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003599:Cytoskeleton; D005434:Flow Cytometry; D018506:Gene Expression Regulation, Plant; D000071677:Histidine Kinase; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism / Q000473:pathology; D012516:Osteosarcoma / Q000378:metabolism / Q000473:pathology; D011494:Protein Kinases / Q000378:metabolism*; D011743:Pyrimidines / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D029681:Arabidopsis Proteins; D002352:Carrier Proteins; D003583:Cytokinins; D011743:Pyrimidines; D011956:Receptors, Cell Surface; D011494:Protein Kinases; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2; D000071677:Histidine Kinase; C000605493:AHK3 protein, Arabidopsis; C421783:WOL protein, Arabidopsis